skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 21,193  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates
Material Type:
Article
Add to My Research

Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates

The Journal of pharmacology and experimental therapeutics, 2014-07, Vol.350 (1), p.46-55 [Peer Reviewed Journal]

Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics. ;Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics 2014 ;ISSN: 0022-3565 ;EISSN: 1521-0103 ;DOI: 10.1124/jpet.113.212407 ;PMID: 24784568

Full text available

2
CpG DNA as a vaccine adjuvant
Material Type:
Article
Add to My Research

CpG DNA as a vaccine adjuvant

Expert review of vaccines, 2011-04, Vol.10 (4), p.499-511 [Peer Reviewed Journal]

Expert Reviews Ltd 2011 ;COPYRIGHT 2011 Expert Reviews Ltd. ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/erv.10.174 ;PMID: 21506647

Full text available

3
Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles
Material Type:
Article
Add to My Research

Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles

Nucleic acids research, 2014-09, Vol.42 (15), p.9996-10004 [Peer Reviewed Journal]

The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research. ;The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research. 2014 ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gku516 ;PMID: 25092921

Full text available

4
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
Material Type:
Article
Add to My Research

Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system

International Journal of Nanomedicine, 2012-01, Vol.7 (default), p.2181-2195 [Peer Reviewed Journal]

2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Hanagata, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1178-2013 ;ISSN: 1176-9114 ;EISSN: 1178-2013 ;DOI: 10.2147/IJN.S30197 ;PMID: 22619554

Full text available

5
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Material Type:
Article
Add to My Research

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Investigational new drugs, 2014-02, Vol.32 (1), p.178-187 [Peer Reviewed Journal]

Springer Science+Business Media New York 2013 ;2015 INIST-CNRS ;Springer Science+Business Media New York 2014 ;ISSN: 0167-6997 ;EISSN: 1573-0646 ;DOI: 10.1007/s10637-013-0045-6 ;PMID: 24242861 ;CODEN: INNDDK

Full text available

6
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
Material Type:
Article
Add to My Research

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Lancet neurology, 2013-05, Vol.12 (5), p.435-442 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 2013 ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(13)70061-9 ;PMID: 23541756 ;CODEN: LANCAO

Full text available

7
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Material Type:
Article
Add to My Research

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

Proceedings of the National Academy of Sciences - PNAS, 2007-05, Vol.104 (21), p.8947-8952 [Peer Reviewed Journal]

Copyright 2007 The National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences May 22, 2007 ;2007 by The National Academy of Sciences of the USA 2007 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.0703395104 ;PMID: 17517626

Full text available

8
Targeting noncoding RNAs in disease
Material Type:
Article
Add to My Research

Targeting noncoding RNAs in disease

The Journal of clinical investigation, 2017-03, Vol.127 (3), p.761-771 [Peer Reviewed Journal]

COPYRIGHT 2017 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Mar 2017 ;Copyright © 2017, American Society for Clinical Investigation 2017 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI84424 ;PMID: 28248199

Full text available

9
Renal Effects of Antisense-Mediated Inhibition of SGLT2
Material Type:
Article
Add to My Research

Renal Effects of Antisense-Mediated Inhibition of SGLT2

The Journal of pharmacology and experimental therapeutics, 2016-11, Vol.359 (2), p.280-289 [Peer Reviewed Journal]

Copyright © 2016 by The Author(s). ;ISSN: 0022-3565 ;EISSN: 1521-0103 ;DOI: 10.1124/jpet.116.233809 ;PMID: 27605629

Full text available

10
Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy
Material Type:
Article
Add to My Research

Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy

PloS one, 2012-11, Vol.7 (11), p.e49006 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 McGowan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 McGowan et al 2012 McGowan et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0049006 ;PMID: 23152839

Full text available

11
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials
Material Type:
Article
Add to My Research

Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials

Clinical cancer research, 2017-10, Vol.23 (19), p.5679-5686 [Peer Reviewed Journal]

2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Oct 1, 2017 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-17-0944 ;PMID: 28972083

Full text available

12
B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids
Material Type:
Article
Add to My Research

B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids

The Journal of immunology (1950), 2017-08, Vol.199 (3), p.931-940 [Peer Reviewed Journal]

Copyright © 2017 by The American Association of Immunologists, Inc. ;Copyright American Association of Immunologists Aug 1, 2017 ;ISSN: 0022-1767 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.1700348 ;PMID: 28652397

Full text available

13
Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
Material Type:
Article
Add to My Research

Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9816-9826 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-10-1251 ;PMID: 20935225 ;CODEN: CNREA8

Full text available

14
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
Material Type:
Article
Add to My Research

Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist

Proceedings of the National Academy of Sciences - PNAS, 2014-02, Vol.111 (8), p.3086-3091 [Peer Reviewed Journal]

copyright © 1993–2008 National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences Feb 25, 2014 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1319268111 ;PMID: 24516163

Full text available

15
Discovery and development of anticancer aptamers
Material Type:
Article
Add to My Research

Discovery and development of anticancer aptamers

Molecular cancer therapeutics, 2006-12, Vol.5 (12), p.2957-2962 [Peer Reviewed Journal]

ISSN: 1535-7163 ;EISSN: 1538-8514 ;DOI: 10.1158/1535-7163.MCT-06-0172 ;PMID: 17172400

Full text available

16
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
Material Type:
Article
Add to My Research

Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia

Blood, 2016-03, Vol.127 (13), p.1687-1700 [Peer Reviewed Journal]

2016 American Society of Hematology ;2016 by The American Society of Hematology. ;2016 by The American Society of Hematology 2016 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2015-08-665604 ;PMID: 26796361

Full text available

17
DEC-205 is a cell surface receptor for CpG oligonucleotides
Material Type:
Article
Add to My Research

DEC-205 is a cell surface receptor for CpG oligonucleotides

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (40), p.16270-16275 [Peer Reviewed Journal]

copyright © 1993-2008 National Academy of Sciences of the United States of America ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1208796109 ;PMID: 22988114

Full text available

18
Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
Material Type:
Article
Add to My Research

Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells

Molecular pharmacology, 2009-11, Vol.76 (5), p.984-991 [Peer Reviewed Journal]

2009 The American Society for Pharmacology and Experimental Therapeutics ;ISSN: 0026-895X ;EISSN: 1521-0111 ;DOI: 10.1124/mol.109.055947 ;PMID: 19657047

Full text available

19
Programmable multistage drug delivery to lymph nodes
Material Type:
Article
Add to My Research

Programmable multistage drug delivery to lymph nodes

Nature nanotechnology, 2020-06, Vol.15 (6), p.491-499 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Nature Limited 2020. ;ISSN: 1748-3387 ;EISSN: 1748-3395 ;DOI: 10.1038/s41565-020-0679-4 ;PMID: 32523099

Full text available

20
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
Material Type:
Article
Add to My Research

Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis

Neuron (Cambridge, Mass.), 2012-06, Vol.74 (6), p.1031-1044 [Peer Reviewed Journal]

2012 Elsevier Inc. ;Copyright © 2012 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 21, 2012 ;2012 Elsevier Inc. All rights reserved. 2012 ;ISSN: 0896-6273 ;EISSN: 1097-4199 ;DOI: 10.1016/j.neuron.2012.05.009 ;PMID: 22726834

Full text available

Results 1 - 20 of 21,193  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (20,454)

Refine My Results

Creation Date 

From To
  1. Before 1980  (298)
  2. 1980 To 1990  (2,050)
  3. 1991 To 2001  (14,188)
  4. 2002 To 2013  (3,698)
  5. After 2013  (959)
  6. More options open sub menu

Resource Type 

  1. Articles  (21,185)
  2. Books  (4)
  3. Reports  (2)
  4. Web Resources  (1)
  5. Thesises (postgraduate)  (1)
  6. More options open sub menu

Language 

  1. English  (21,159)
  2. Japanese  (4,924)
  3. German  (15)
  4. French  (10)
  5. Russian  (8)
  6. Chinese  (5)
  7. Portuguese  (4)
  8. Spanish  (4)
  9. Korean  (2)
  10. Dutch  (1)
  11. More options open sub menu

Searching Remote Databases, Please Wait